Nov 02, 2021 6:13pm EDT XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange
Oct 13, 2021 7:55am EDT XORTX Therapeutics Announces Pricing of US$12 Million Public Offering and Nasdaq Listing